(Q33689204)

28 July 2017

1 reference

title

Naratriptan: an alternative for migraine (English)

1 reference

28 July 2017

1 reference

D A Dulli

1

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 June 1999

1 reference

Annals of Pharmacotherapy

28 July 2017

published in

1 reference

28 July 2017

volume

33

1 reference

28 July 2017

issue

6

1 reference

28 July 2017

page(s)

704-711

1 reference

Burden of migraine: societal costs and therapeutic opportunities

28 July 2017

cites work

1 reference

Serotonin 1D (5-HT1D) agonists and other agents in acute migraine

21 January 2018

1 reference

21 January 2018

1 reference

Naratriptan: biological profile in animal models relevant to migraine

21 January 2018

1 reference

Inhibition of trigeminal neurones after intravenous administration of naratriptan through an action at 5-hydroxy-tryptamine (5-HT(1B/1D)) receptors

21 January 2018

1 reference

The pharmacodynamics and pharmacokinetics of the 5HT1B/1D-agonist zolmitriptan in healthy young and elderly men and women.

21 January 2018

1 reference

Naratriptan is effective and well tolerated in the acute treatment of migraine. Results of a double-blind, placebo-controlled, parallel-group study. Naratriptan S2WA3001 Study Group

21 January 2018

1 reference

Naratriptan is effective and well tolerated in the acute treatment of migraine. Results of a double-blind, placebo-controlled, crossover study. The Naratriptan S2WA3003 Study Group

21 January 2018

1 reference

Tolerability and efficacy of naratriptan tablets with long-term treatment (6 months). Naratriptan Long-term Study Group

21 January 2018

1 reference

Double-blind, placebo-controlled, dose-finding study of rizatriptan (MK-462) in the acute treatment of migraine

21 January 2018

1 reference

Rizatriptan (MAXALT) for the acute treatment of migraine and migraine recurrence. A placebo-controlled, outpatient study. Rizatriptan 022 Study Group

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.18300

1 reference

28 July 2017

1 reference